文献速递消化道出血消化内镜

英国急性上消化道出血2022年审计更新

Acute upper gastrointestinal bleeding in the UK: 2022 audit update.
PubMed 文献 · Gut · 2026-03-06

2022年英国147家医院前瞻性多中心审计纳入5141例急性上消化道出血成人患者,与2007年审计相比,患者合并症、肝硬化和抗凝药使用更多,但再出血率(9.7% vs 13.3%)、院内死亡率(8.8% vs 10.0%)和住院时间(5 vs 6天)均改善;不适当输血(Hb>80 g/L)与调整后死亡率升高相关(aOR 1.60,95%CI 1.00-2.56)。

要点

  • 2022年审计中42%患者未行内镜前风险分层,输血阈值和风险分层依从性不足。
  • 稳定患者Hb>80 g/L的不适当输血与调整后死亡率升高相关(aOR 1.60,95%CI 1.00-2.56)。
  • 再出血率、院内死亡率和住院时间较2007年改善,但补救治疗率不变且从手术转向介入放射。

核心结论

  • 尽管病例组合风险更高且指南依从性不完全,急性上消化道出血的结局已改善。
  • 稳定患者Hb>80 g/L的宽松输血与死亡率升高相关,支持限制性输血策略。

研究设计与样本

  • 2022年5月3日至7月2日前瞻性多中心审计,纳入英国147家医院≥16岁急性上消化道出血成人患者。
  • 共5141例患者(59%男性,中位年龄69岁),随访至出院、死亡或28天。
  • 与2007年审计比较,应答率86%(2007年84%)。

主要发现

  • 2022年患者合并症67%(2007年50%)、肝硬化15%(9%)、抗凝药使用31%(13%)和输血率50%(43%)均更高。
  • 消化性溃疡占32%,静脉曲张占10%,33%未发现异常。
  • 早期输血占38%,其中43%在Hb>70 g/L时给予,24%因血流动力学稳定被归类为不适当。
  • 不适当输血在Hb>80 g/L时与调整后死亡率升高相关(aOR 1.60,95%CI 1.00-2.56),在70 g/L时与再出血无关。
  • 住院期间内镜83%(2007年74%),内镜治疗27%(23%),补救治疗率3.3%(3.1%)但从手术转向介入放射。

关键数值与推荐

  • 急性上消化道出血定义为医务人员确认的呕血、便血、咖啡样呕吐或黑便。
  • 内镜前风险分层未执行率42%。
  • 早期输血指内镜检查前或24小时内输血,占38%。

临床怎么用

  • 对急性上消化道出血患者应执行内镜前风险分层,并遵循限制性输血策略。
  • 稳定患者避免在Hb>80 g/L时常规输血,以减少潜在死亡风险。
  • 加强内镜培训和多学科协作可能进一步改善结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute upper gastrointestinal bleeding (AUGIB) is a common medical emergency with evolving demographics and management strategies, particularly in medical/endoscopic therapy and transfusion strategies. OBJECTIVE: To provide key data of the most recent 2022 UK audit and compare it with the preceding audit in 2007. DESIGN: Prospective multicentre audit conducted from 3 May to 2 July 2022, including adults (≥16 years) with AUGIB across 147 UK hospitals (response rate 86% vs 84% in 2007). AUGIB was defined by clinical symptoms (haematemesis, haematochezia, coffee ground vomiting or melaena confirmed by medical personnel). Patients were followed until discharge, death or 28 days, with re-admissions during the study period counted as new episodes. RESULTS: Among 5141 patients (59% male; median age 69), 15% had cirrhosis, 19% reported excess alcohol use, 7% used non-steroidal anti-inflammatory drugs (NSAIDs) and 46% were on antithrombotics. Most (77%) were new admissions, who were younger with fewer comorbidities, while the remainder bled during hospitalisation. Peptic ulcer disease accounted for 32% of cases, varices for 10% and no abnormality was found in 33%. Pre-endoscopic risk stratification was not performed in 42%.Compared with 2007, patients in 2022 had higher comorbidity (67% vs 50%), more cirrhosis (15% vs 9%), greater anticoagulant use (31% vs 13%) and higher transfusion rates (50% vs 43%). In 2022, among early transfusions (pre-endoscopy or within first 24 hrs; 38%), 43% were given at haemoglobin (Hb)>70 g/L, with 24% classified as inappropriate due to haemodynamic stability. A signal of harm was observed: while inappropriate transfusion was not associated with rebleeding at either 70 or 80 g/L, at 80 g/L it was linked to higher adjusted mortality (adjusted OR (aOR) 1.60, 95% CI 1.00 to 2.56).Inpatient endoscopy was more common (83% vs 74%), though endotherapy use remained modest (27% vs 23%). Salvage therapy rates were unchanged (3.3% vs 3.1%) but shifted from surgery to interventional radiology. Outcomes improved, with lower rebleeding (9.7% vs 13.3%), reduced in-hospital mortality (8.8% vs 10.0%) and shorter median stay (5 vs 6 days). In multivariate analysis, mortality was independently predicted by older age (≥80 years: aOR 2.32, 95% CI 1.64 to 3.30), shock (aOR 2.22, 95% CI 1.53 to 3.17) and comorbidity, while lower Hb at presentation increased risk (≤70 g/L: aOR 1.56, 95% CI 1.15 to 2.11). Anticoagulant use was associated with increased mortality (aOR 1.43, 95% CI 1.11 to 1.85), whereas NSAID use (aOR 0.49, 95% CI 0.25 to 0.96) and antiplatelet use (aOR 0.68, 95% CI 0.54 to 0.87) were associated with lower mortality. CONCLUSIONS: Despite a higher-risk case mix and incomplete adherence to guidelines (notably in transfusion thresholds and risk stratification), outcomes in AUGIB have improved. The observation of increased mortality with liberal transfusion above 80 g/L in stable patients reinforces the importance of restrictive transfusion practice. Quality improvement initiatives focused on risk stratification, endoscopic training and multidisciplinary care could further enhance outcomes in the UK and internationally.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Nigam GB, Oakland K, Hearnshaw S, et al. Acute upper gastrointestinal bleeding in the UK: 2022 audit update. Gut. 2026. PMID: 41260910. doi:10.1136/gutjnl-2025-335134

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。